Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A mutation in Hnrnph1 that decreases methamphetamine-induced reinforcement, reward, and dopamine release and increases synaptosomal hnRNP H and mitochondrial proteins.

Ruan QT, Yazdani N, Blum BC, Beierle JA, Lin W, Coelho MA, Fultz EK, Healy AF, Shahin JR, Kandola AK, Luttik KP, Zheng K, Smith NJ, Cheung J, Mortazavi F, Apicco DJ, Ragu Varman D, Ramamoorthy S, Ash PEA, Rosene DL, Emili A, Wolozin B, Szumlinski KK, Bryant CD.

J Neurosci. 2019 Nov 8. pii: 1808-19. doi: 10.1523/JNEUROSCI.1808-19.2019. [Epub ahead of print]

PMID:
31704785
2.

Cyfip1 Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on Cyfip2 Genetic Background, Parent-of Origin, and Sex.

Babbs RK, Beierle JA, Ruan QT, Kelliher JC, Chen MM, Feng AX, Kirkpatrick SL, Benitez FA, Rodriguez FA, Pierre JJ, Anandakumar J, Kumar V, Mulligan MK, Bryant CD.

G3 (Bethesda). 2019 Sep 4;9(9):3009-3022. doi: 10.1534/g3.119.400470.

3.

Identification of a Functional Non-coding Variant in the GABA A Receptor α2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience Research.

Mulligan MK, Abreo T, Neuner SM, Parks C, Watkins CE, Houseal MT, Shapaker TM, Hook M, Tan H, Wang X, Ingels J, Peng J, Lu L, Kaczorowski CC, Bryant CD, Homanics GE, Williams RW.

Front Genet. 2019 Mar 29;10:188. doi: 10.3389/fgene.2019.00188. eCollection 2019.

4.

C57BL/6 substrain differences in inflammatory and neuropathic nociception and genetic mapping of a major quantitative trait locus underlying acute thermal nociception.

Bryant CD, Bagdas D, Goldberg LR, Khalefa T, Reed ER, Kirkpatrick SL, Kelliher JC, Chen MM, Johnson WE, Mulligan MK, Imad Damaj M.

Mol Pain. 2019 Jan-Dec;15:1744806918825046. doi: 10.1177/1744806918825046.

5.

Genetic differences in the behavioral organization of binge eating, conditioned food reward, and compulsive-like eating in C57BL/6J and DBA/2J strains.

Babbs RK, Kelliher JC, Scotellaro JL, Luttik KP, Mulligan MK, Bryant CD.

Physiol Behav. 2018 Dec 1;197:51-66. doi: 10.1016/j.physbeh.2018.09.013. Epub 2018 Sep 24.

PMID:
30261172
6.

Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation.

Ruan QT, Yazdani N, Beierle JA, Hixson KM, Hokenson KE, Apicco DJ, Luttik KP, Zheng K, Maziuk BF, Ash PEA, Szumlinski KK, Russek SJ, Wolozin B, Bryant CD.

Neurosci Lett. 2018 Sep 25;684:109-114. doi: 10.1016/j.neulet.2018.07.015. Epub 2018 Jul 9.

7.

Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo.

Apicco DJ, Ash PEA, Maziuk B, LeBlang C, Medalla M, Al Abdullatif A, Ferragud A, Botelho E, Ballance HI, Dhawan U, Boudeau S, Cruz AL, Kashy D, Wong A, Goldberg LR, Yazdani N, Zhang C, Ung CY, Tripodis Y, Kanaan NM, Ikezu T, Cottone P, Leszyk J, Li H, Luebke J, Bryant CD, Wolozin B.

Nat Neurosci. 2018 Jan;21(1):72-80. doi: 10.1038/s41593-017-0022-z. Epub 2017 Nov 20.

8.

Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1.

Goldberg LR, Kirkpatrick SL, Yazdani N, Luttik KP, Lacki OA, Babbs RK, Jenkins DF, Johnson WE, Bryant CD.

Genes Brain Behav. 2017 Sep;16(7):725-738. doi: 10.1111/gbb.12397. Epub 2017 Jul 6. Erratum in: Genes Brain Behav. 2017 Nov;16(8):823.

9.

Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating.

Kirkpatrick SL, Goldberg LR, Yazdani N, Babbs RK, Wu J, Reed ER, Jenkins DF, Bolgioni AF, Landaverde KI, Luttik KP, Mitchell KS, Kumar V, Johnson WE, Mulligan MK, Cottone P, Bryant CD.

Biol Psychiatry. 2017 May 1;81(9):757-769. doi: 10.1016/j.biopsych.2016.10.021. Epub 2016 Oct 25.

10.

Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test.

Young EE, Bryant CD, Lee SE, Peng X, Cook B, Nair HK, Dreher KJ, Zhang X, Palmer AA, Chung JM, Mogil JS, Chesler EJ, Lariviere WR.

Genes Brain Behav. 2016 Jul;15(6):604-15. doi: 10.1111/gbb.12302.

11.

Striatal transcriptome analysis of a congenic mouse line (chromosome 11: 50-60Mb) exhibiting reduced methamphetamine sensitivity.

Yazdani N, Shen Y, Johnson WE, Bryant CD.

Genom Data. 2016 Apr 11;8:77-80. doi: 10.1016/j.gdata.2016.03.009. eCollection 2016 Jun.

12.

Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity.

Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD.

PLoS Genet. 2015 Dec 10;11(12):e1005713. doi: 10.1371/journal.pgen.1005713. eCollection 2015 Dec.

13.

RNA-binding proteins, neural development and the addictions.

Bryant CD, Yazdani N.

Genes Brain Behav. 2016 Jan;15(1):169-86. doi: 10.1111/gbb.12273. Review.

14.

A new approach to control haemorrhage during lower lip shave.

Bryant CD, Han LE.

Br J Oral Maxillofac Surg. 2016 Jul;54(6):715. doi: 10.1016/j.bjoms.2015.09.026. Epub 2015 Oct 21. No abstract available.

PMID:
26499387
15.

Behavioral architecture of opioid reward and aversion in C57BL/6 substrains.

Kirkpatrick SL, Bryant CD.

Front Behav Neurosci. 2015 Jan 12;8:450. doi: 10.3389/fnbeh.2014.00450. eCollection 2014.

16.

The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice.

Zhou L, Bryant CD, Loudon A, Palmer AA, Vitaterna MH, Turek FW.

Sleep. 2014 Apr 1;37(4):785-93, 793A-793C. doi: 10.5665/sleep.3590.

17.

The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line.

Bryant CD, Guido MA, Kole LA, Cheng R.

Addict Biol. 2014 Jul;19(4):552-61. doi: 10.1111/adb.12016. Epub 2012 Dec 12.

18.

Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line.

Bryant CD, Kole LA, Guido MA, Cheng R, Palmer AA.

Front Genet. 2012 Jul 11;3:126. doi: 10.3389/fgene.2012.00126. eCollection 2012.

19.

Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis.

Bryant CD, Kole LA, Guido MA, Sokoloff G, Palmer AA.

Genes Brain Behav. 2012 Jul;11(5):623-32. doi: 10.1111/j.1601-183X.2012.00795.x. Epub 2012 May 2. Erratum in: Genes Brain Behav. 2012 Oct;11(7):888.

20.

The blessings and curses of C57BL/6 substrains in mouse genetic studies.

Bryant CD.

Ann N Y Acad Sci. 2011 Dec;1245:31-3. doi: 10.1111/j.1749-6632.2011.06325.x.

21.

Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.

Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA.

Neuropsychopharmacology. 2012 Mar;37(4):1026-35. doi: 10.1038/npp.2011.287. Epub 2011 Nov 16.

22.

Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal.

Hofford RS, Hodgson SR, Roberts KW, Bryant CD, Evans CJ, Eitan S.

Behav Pharmacol. 2009 Oct;20(7):576-83. doi: 10.1097/FBP.0b013e32832ec57e.

23.

A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice.

Bryant CD, Chang HP, Zhang J, Wiltshire T, Tarantino LM, Palmer AA.

Genes Brain Behav. 2009 Nov;8(8):795-805. doi: 10.1111/j.1601-183X.2009.00525.x. Epub 2009 Jul 21.

24.

Pavlovian conditioning of multiple opioid-like responses in mice.

Bryant CD, Roberts KW, Culbertson CS, Le A, Evans CJ, Fanselow MS.

Drug Alcohol Depend. 2009 Jul 1;103(1-2):74-83. doi: 10.1016/j.drugalcdep.2009.03.016. Epub 2009 May 5.

25.

Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies.

Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, McRoberts JA.

J Neurogenet. 2008;22(4):315-31. doi: 10.1080/01677060802357388.

26.

A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine.

Bryant CD, Graham ME, Distler MG, Munoz MB, Li D, Vezina P, Sokoloff G, Palmer AA.

Psychopharmacology (Berl). 2009 May;203(4):703-11. doi: 10.1007/s00213-008-1417-z. Epub 2008 Dec 3.

27.

Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice.

Gioiosa L, Chen X, Watkins R, Klanfer N, Bryant CD, Evans CJ, Arnold AP.

Horm Behav. 2008 Jan;53(1):124-30. Epub 2007 Sep 14.

28.

Demand management and case management: a conservation strategy.

Bryant CD.

Prof Case Manag. 2007 Sep-Oct;12(5):272-80; quiz 281-2. Review.

PMID:
17885633
29.

Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice.

Bryant CD, Roberts KW, Byun JS, Fanselow MS, Evans CJ.

Pharmacol Biochem Behav. 2006 Dec;85(4):769-79. Epub 2006 Dec 28.

30.

NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice.

Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ.

Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R315-26. Epub 2006 Apr 6.

31.

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ.

J Neurosci. 2003 Nov 12;23(32):10331-7.

32.
33.

The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice.

Wilson SG, Bryant CD, Lariviere WR, Olsen MS, Giles BE, Chesler EJ, Mogil JS.

J Pharmacol Exp Ther. 2003 May;305(2):755-64. Epub 2003 Feb 20.

PMID:
12606637
34.

Myotonic dystrophy: case report and review of the literature.

Bryant CD.

J S C Med Assoc. 1980 Jun;76(6):289-91. No abstract available.

PMID:
6929939
35.

Changing career specialties within veterinary medicine.

Snizek WE, Bryant CD.

Am J Public Health. 1976 Apr;66(4):381-2. No abstract available.

Supplemental Content

Loading ...
Support Center